Keyphrases
Giardia Lamblia
100%
Giardia
53%
Propolis
40%
Locally Advanced Breast Cancer
33%
Trophozoite
26%
Immunogenic Antigens
20%
Latin America (LATAM)
20%
Infected Mice
20%
Caffeic Acid Phenethyl Ester
19%
Breast Cancer Research
19%
Partial Characterization
19%
Immunogenic Proteins
18%
Chemical Constituents
18%
Chemical Composition
18%
In Vitro Growth
16%
Transcriptomics
16%
Specific T Cells
16%
Pragmatic Trial
16%
Immunoglobulin-binding Protein
16%
Immunogen
16%
Mouse Infection
16%
Host Defense
16%
Protective Effect
16%
Prognostic Value
16%
Cancer Cell Lines
16%
Tumor
16%
Latin American Patient
16%
T Cells
16%
Monoclonal Antibody
16%
Oxidative Stress
16%
T Cell Hybridomas
16%
Antiproliferative Activity
16%
IC50
13%
Luma
13%
Cellular Antioxidant Activity
13%
PAM50
13%
Humoral Immune Response
12%
Adjusted Hazard Ratio
12%
Molecular Profiling
12%
Cellular Immune Response
12%
Latin American
10%
Basal-like Tumors
10%
Galangin
8%
Type of Surgery
8%
Breast Reconstruction
8%
Residual Cancer Burden
8%
Rutin
8%
B Cells
7%
Immunological Characterization
7%
Human Epidermal Growth Factor Receptor 2 (HER2)
7%
Immunology and Microbiology
Giardia intestinalis
85%
Giardia
60%
Trophozoite
30%
Adoptive Immunity
23%
T Cell
20%
Humoral Immunity
18%
Hybridoma
16%
Immunoglobulin Binding
16%
Host Resistance
16%
IC50
16%
Oxidative Stress
16%
Monoclonal Antibody
16%
Tandem Mass Spectrometry
16%
Antioxidant Activity
16%
Immune Response
12%
B Cell
12%
Electrospray Ionization
11%
Giardiasis
10%
T-Helper Cell
9%
Macrophage
8%
Epitope
7%
Electrospray
5%
Affinity Chromatography
5%
Protein Family
5%
Bioinformatics
5%
Cell Lysate
5%
Medicine and Dentistry
Locally Advanced Breast Cancer
33%
Breast Cancer
29%
Hazard Ratio
16%
Molecular Profiling
16%
Transcriptomics
16%
Caffeic Acid Phenethyl Ester
16%
Neoplasm
16%
Oxidative Stress
16%
Antioxidant Capacity
13%
Malignant Neoplasm
13%
Quadrantectomy
11%
Hormone Receptor
7%
Rutin
6%
Propolis
6%
Galangin
6%
Macrophage
6%
Antioxidant
6%
Cancer Mortality
5%
Health Disparity
5%
Neoadjuvant Chemotherapy
5%
Neoadjuvant Therapy
5%
Cancer Research
5%
Oncology
5%
Trastuzumab
5%
Mastectomy
5%
Patient Compliance
5%
Mortality Rate
5%
Arm
5%
Clinical Research
5%
Diseases
5%
Epidermal Growth Factor Receptor 2
5%
Gamma Urogastrone
5%
Overall Survival
5%
